TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 43 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,584,000 | +0.6% | 2,400,000 | 0.0% | 0.09% | +3.4% |
| Q1 2017 | $2,568,000 | +184.1% | 2,400,000 | +272.1% | 0.09% | +155.9% |
| Q2 2015 | $904,000 | -55.0% | 645,000 | -52.2% | 0.03% | -55.3% |
| Q1 2015 | $2,009,000 | +22.6% | 1,350,000 | +12.5% | 0.08% | 0.0% |
| Q4 2014 | $1,639,000 | -74.0% | 1,200,000 | -75.5% | 0.08% | -70.1% |
| Q3 2014 | $6,297,000 | -3.3% | 4,900,000 | -3.0% | 0.25% | -1.9% |
| Q2 2014 | $6,515,000 | +9.1% | 5,050,000 | +7.4% | 0.26% | +4.4% |
| Q1 2014 | $5,970,000 | +107.2% | 4,700,000 | +74.1% | 0.25% | +105.0% |
| Q4 2013 | $2,881,000 | – | 2,700,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |